Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action.
J Aerosol Med Pulm Drug Deliv
; 35(6): 321-332, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36108289
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dihydroergotamine
/
Migraine Disorders
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Aerosol Med Pulm Drug Deliv
Journal subject:
TERAPIA POR MEDICAMENTOS
Year:
2022
Document type:
Article
Affiliation country:
United States